Adam M Veness, Senior Vice President, General Counsel and Secretary, on August 07, 2026, sold 20,000 shares in Dianthus Therapeutics (DNTH) for $2,208,833.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1690585/000177862326000007/xslF345X05/ownership.xml